Literature DB >> 27140399

Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease.

Elaheh Ekhtiari Bidhendi, Johan Bergh, Per Zetterström, Peter M Andersen, Stefan L Marklund, Thomas Brännström.   

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult-onset degeneration of motor neurons that is commonly caused by mutations in the gene encoding superoxide dismutase 1 (SOD1). Both patients and Tg mice expressing mutant human SOD1 (hSOD1) develop aggregates of unknown importance. In Tg mice, 2 different strains of hSOD1 aggregates (denoted A and B) can arise; however, the role of these aggregates in disease pathogenesis has not been fully characterized. Here, minute amounts of strain A and B hSOD1 aggregate seeds that were prepared by centrifugation through a density cushion were inoculated into lumbar spinal cords of 100-day-old mice carrying a human SOD1 Tg. Mice seeded with A or B aggregates developed premature signs of ALS and became terminally ill after approximately 100 days, which is 200 days earlier than for mice that had not been inoculated or were given a control preparation. Concomitantly, exponentially growing strain A and B hSOD1 aggregations propagated rostrally throughout the spinal cord and brainstem. The phenotypes provoked by the A and B strains differed regarding progression rates, distribution, end-stage aggregate levels, and histopathology. Together, our data indicate that the aggregate strains are prions that transmit a templated, spreading aggregation of hSOD1, resulting in a fatal ALS-like disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27140399      PMCID: PMC4887173          DOI: 10.1172/JCI84360

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

Authors:  L I Bruijn; M W Becher; M K Lee; K L Anderson; N A Jenkins; N G Copeland; S S Sisodia; J D Rothstein; D R Borchelt; D L Price; D W Cleveland
Journal:  Neuron       Date:  1997-02       Impact factor: 17.173

2.  Experimental transmissibility of mutant SOD1 motor neuron disease.

Authors:  Jacob I Ayers; Susan Fromholt; Morgan Koch; Adam DeBosier; Ben McMahon; Guilian Xu; David R Borchelt
Journal:  Acta Neuropathol       Date:  2014-09-28       Impact factor: 17.088

Review 3.  Mouse models for studying the formation and propagation of prions.

Authors:  Joel C Watts; Stanley B Prusiner
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 4.  New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes.

Authors:  S Kato; M Takikawa; K Nakashima; A Hirano; D W Cleveland; H Kusaka; N Shibata; M Kato; I Nakano; E Ohama
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-06

5.  Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.

Authors:  P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Mikael Lindberg; Mikael Oliveberg; Stefan L Marklund
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

6.  Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping.

Authors:  Johan Bergh; Per Zetterström; Peter M Andersen; Thomas Brännström; Karin S Graffmo; P Andreas Jonsson; Lisa Lang; Jens Danielsson; Mikael Oliveberg; Stefan L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

7.  Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells.

Authors:  Christian Münch; John O'Brien; Anne Bertolotti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

8.  Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.

Authors:  Per Zetterström; Heather G Stewart; Daniel Bergemalm; P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Mikael Oliveberg; Stefan L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

9.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

10.  Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutase.

Authors:  Eiichi Tokuda; Thomas Brännström; Peter M Andersen; Stefan L Marklund
Journal:  Acta Neuropathol Commun       Date:  2016-01-25       Impact factor: 7.801

View more
  30 in total

1.  Transfer of pathogenic and nonpathogenic cytosolic proteins between spinal cord motor neurons in vivo in chimeric mice.

Authors:  Eleanor V Thomas; Wayne A Fenton; James McGrath; Arthur L Horwich
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 2.  Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy.

Authors:  Caroline Sibilla; Anne Bertolotti
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

3.  Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.

Authors:  Jacob I Ayers; Jeffrey Diamond; Adriana Sari; Susan Fromholt; Ahmad Galaleldeen; Lyle W Ostrow; Jonathan D Glass; P John Hart; David R Borchelt
Journal:  Acta Neuropathol       Date:  2016-10-04       Impact factor: 17.088

4.  Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models.

Authors:  Jacob I Ayers; Benjamin McMahon; Sabrina Gill; Herman L Lelie; Susan Fromholt; Hilda Brown; Joan Selverstone Valentine; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2016-11-25       Impact factor: 5.372

Review 5.  Prionoids in amyotrophic lateral sclerosis.

Authors:  Philippe Gosset; William Camu; Cedric Raoul; Alexandre Mezghrani
Journal:  Brain Commun       Date:  2022-06-09

Review 6.  Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis.

Authors:  S Bräuer; V Zimyanin; A Hermann
Journal:  J Neural Transm (Vienna)       Date:  2018-02-08       Impact factor: 3.575

7.  A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity.

Authors:  Victor Banerjee; Ofek Oren; Efrat Ben-Zeev; Ran Taube; Stanislav Engel; Niv Papo
Journal:  J Biol Chem       Date:  2017-08-02       Impact factor: 5.157

8.  Variation in the vulnerability of mice expressing human superoxide dismutase 1 to prion-like seeding: a study of the influence of primary amino acid sequence.

Authors:  Jacob I Ayers; Guilian Xu; Kristy Dillon; Qing Lu; Zhijuan Chen; John Beckman; Alma K Moreno-Romero; Diana L Zamora; Ahmad Galaleldeen; David R Borchelt
Journal:  Acta Neuropathol Commun       Date:  2021-05-20       Impact factor: 7.578

Review 9.  A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis.

Authors:  E Srinivasan; R Rajasekaran
Journal:  J Mol Neurosci       Date:  2020-05-15       Impact factor: 3.444

10.  Peripheral administration of SOD1 aggregates does not transmit pathogenic aggregation to the CNS of SOD1 transgenic mice.

Authors:  Isil Keskin; Elaheh Ekhtiari Bidhendi; Matthew Marklund; Peter M Andersen; Thomas Brännström; Stefan L Marklund; Ulrika Nordström
Journal:  Acta Neuropathol Commun       Date:  2021-06-22       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.